Physiology of the incretin hormones, GIP and GLP-1regulation of release and post-translational modifications
The drugmakers, she says, spent a lot of time and money to bring these drugs to market and will want to assert their intellectual property claims and regain market share
Min SY, Kim HS, Jung EJ, Jung EJ, Jee CD, Kim WH
This article provides a comprehensive guide for individuals considering or undergoing a switch from semaglutide to tirzepatide and offers practical guidance and insights beyond the currently available information
It also brings side effects we dont see with Mounjaro, including a larger increase in heart rate
Retatrutide is a new entry in the class of GLP-1 agonist drugs, which mimic an anti-diabetes/anti-obesity hormone called GLP-1 and keep levels up to 1,000 times higher than normal